LGT Capital Partners’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-370,000
Closed -$4.39M 57
2024
Q2
$4.39M Sell
370,000
-220,000
-37% -$2.51M 0.15% 49
2024
Q1
$7.09M Buy
590,000
+105,000
+22% +$1.56M 0.22% 47
2023
Q4
$8.17M Hold
485,000
0.24% 44
2023
Q3
$7.27M Hold
485,000
0.26% 48
2023
Q2
$9.14M Hold
485,000
0.32% 47
2023
Q1
$8.69M Hold
485,000
0.24% 45
2022
Q4
$4.04M Hold
485,000
0.12% 56
2022
Q3
$3.31M Buy
485,000
+40,000
+9% +$665K 0.1% 57
2022
Q2
$8.72M Sell
445,000
-40,000
-8% -$838K 0.27% 43
2022
Q1
$10.5M Buy
485,000
+120,000
+33% +$2.55M 0.3% 42
2021
Q4
$8.6M Buy
365,000
+30,000
+9% +$718K 0.23% 44
2021
Q3
$8.76M Buy
335,000
+130,000
+63% +$3.15M 0.26% 42
2021
Q2
$4.97M Buy
205,000
+35,000
+21% +$861K 0.14% 64
2021
Q1
$4.24M Sell
170,000
-10,000
-6% -$264K 0.14% 59
2020
Q4
$4.94M Buy
+180,000
New +$4.83M 0.17% 62

Other funds holding SHC

LGT Capital Partners's SHC Position: Q3 2024 in Review

LGT Capital Partners sold out of Sotera Health (SHC) in Q3 2024, closing a stake of 370,000 shares — an estimated $4.39M sold.

LGT Capital Partners first reported a position in SHC in Q4 2020 and held it in 15 quarters. The position peaked at $10.5M in Q1 2022. 209 funds tracked by Wall St. Rank hold SHC as of Q3 2024.

  • LGT Capital Partners reported no remaining Sotera Health position as of Q3 2024 after selling out during the quarter.
  • LGT Capital Partners sold 370,000 Sotera Health shares in Q3 2024, an estimated $4.39M.
  • LGT Capital Partners first reported a position in Sotera Health in Q4 2020 and held it in 15 quarters.
  • LGT Capital Partners's Sotera Health position peaked at $10.5M in Q1 2022.
  • 209 funds tracked by Wall St. Rank held Sotera Health as of Q3 2024.

Based on LGT Capital Partners's 13F filing for Q3 2024, filed 8 Nov 2024.